Clinical Trial Update: Repair of Challenging Abdominal Wall Defects: Strattice(TM) TM in Abdominal Wall Repair (StAR) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Strattice for repairing challenging abdominal wall defects was terminated, with results posted in November 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Hernia
• Surgical Wound Dehiscence

Drugs mentioned

• Strattice

Snippet

Sponsor: LifeCell | Conditions: Hernia, Surgical Wound Dehiscence | Phase 4 | Status: TERMINATED | Results posted: 2013-11-19